Prosecution Insights
Last updated: November 04, 2026

Qbiotix Limited

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Qbiotix Limited has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to CASH, KAILEY ELIZABETH, who is the busiest examiner for the company. The portfolio is currently limited to 1 distinct examiner and a single distinct art unit.

This indicates a highly focused approach to its active US patent prosecution. With only 1 pending office action, the company's immediate progress in the biotech sector depends on the interaction with CASH, KAILEY ELIZABETH. The concentration in one art unit suggests a specialized technical focus that has not yet branched into broader pharmaceutical disciplines.

Practitioners should analyze the examiner's historical allowance rates to better predict the timeline for this case. Because the entire active workload resides with an individual official, the company's patent strategy is sensitive to that person's specific requirements. Future expansion may require navigating additional art units as the company broadens its biotech filing strategy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CASH, KAILEY ELIZABETH 1 28.6% +64.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18262331 TARGET-DEPENDENT POLYMERISATION OF OLIGONUCLEOTIDES CASH, KAILEY ELIZABETH —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18262331 TARGET-DEPENDENT POLYMERISATION OF OLIGONUCLEOTIDES CASH, KAILEY ELIZABETH —

Top Art Units

Art UnitApps
1683 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18262331 TARGET-DEPENDENT POLYMERISATION OF OLIGONUCLEOTIDES CASH, KAILEY ELIZABETH 1683 §102§103§112 Non-Final OA — Pending Jul 20, 2023

Managing Qbiotix Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Qbiotix Limited have?

Qbiotix Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Qbiotix Limited applications?

Kailey Elizabeth Cash has the most, with 1 of Qbiotix Limited's pending office actions.

What technology area are Qbiotix Limited's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month